Gene · 1195
Papers1,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of CMGC kinases by hypoxia. | BMB Rep | 2023 | 37915135 | PubTator, text mining | PubMed |
| Versatile On-Chip Programming of Circuit Hardware for Wearable and Implantable Biomedical Microdevices. | Adv Sci (Weinh) | 2023 | 37904645 | PubTator, text mining | PubMed |
| Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study. | Rheumatol Ther | 2023 | 37902943 | PubTator, text mining | PubMed |
| Insights from the protein interaction Universe of the multifunctional "Goldilocks" kinase DYRK1A. | Front Cell Dev Biol | 2023 | 37900285 | PubTator, text mining | PubMed |
| Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential. | J Exp Clin Cancer Res | 2023 | 37880792 | PubTator, text mining | PubMed |
| RNA therapy is shining for genetic diseases. | Mol Ther Nucleic Acids | 2023 | 37876533 | PubTator, text mining | PubMed |
| Different seminal ejaculated fractions in artificial insemination condition the protein cargo of oviductal and uterine extracellular vesicles in pig. | Front Cell Dev Biol | 2023 | 37868907 | PubTator, text mining | PubMed |
| Crosstalk between m6A modification and alternative splicing during cancer progression. | Clin Transl Med | 2023 | 37850412 | PubTator, text mining | PubMed |
| Discovery and Synthesis of a Naturally Derived Protein Kinase Inhibitor that Selectively Inhibits Distinct Classes of Serine/Threonine Kinases. | J Nat Prod | 2023 | 37843072 | PubTator, text mining | PubMed |
| Editorial: Current omics-based approaches as tools for improving the understanding, diagnosis and management of inflammatory lung disease. | Front Med (Lausanne) | 2023 | 37817810 | PubTator, text mining | PubMed |
| PDIVAS: Pathogenicity predictor for Deep-Intronic Variants causing Aberrant Splicing. | BMC Genomics | 2023 | 37817060 | PubTator, text mining | PubMed |
| Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA. | Nucleic Acids Res | 2023 | 37811881 | PubTator, text mining | PubMed |
| Implementation of Wavelet-Transform-Based Algorithms in an FPGA for Heart Rate and RT Interval Automatic Measurements in Real Time: Application in a Long-Term Ambulatory Electrocardiogram Monitor. | Micromachines (Basel) | 2023 | 37763911 | PubTator, text mining | PubMed |
| An Updated Review on Developing Small Molecule Kinase Inhibitors Using Computer-Aided Drug Design Approaches. | Int J Mol Sci | 2023 | 37762253 | PubTator, text mining | PubMed |
| On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine. | J Virol | 2023 | 37706687 | PubTator, text mining | PubMed |
| Dominant constraints on the evolution of rhythmic gene expression. | Comput Struct Biotechnol J | 2023 | 37692081 | PubTator, text mining | PubMed |
| The Case for the Target of Rapamycin Pathway as a Candidate Circadian Oscillator. | Int J Mol Sci | 2023 | 37686112 | PubTator, text mining | PubMed |
| Steroid receptor coactivator TAIMAN is a new modulator of insect circadian clock. | PLoS Genet | 2023 | 37683015 | PubTator, text mining | PubMed |
| Exploring chemical space for lead identification by propagating on chemical similarity network. | Comput Struct Biotechnol J | 2023 | 37680266 | PubTator, text mining | PubMed |
| Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. | PLoS Pathog | 2023 | 37669313 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1195/papers?page=8